Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets.
about
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplantsChimeric vessel tissue engineering driven by endothelialized modules in immunosuppressed Sprague-Dawley ratsThe endothelial cells in islets of langerhans.Pancreatic islet transplantation for treating diabetes.Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids.Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy.Allogeneic islet transplantation.Cellular therapies for type 1 diabetes.Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cellsOxygenation of the Intraportally Transplanted Pancreatic Islet.Islet transplantation a decade later and strategies for filling a half-full glassEncapsulated cell grafts to treat cellular deficiencies and dysfunction.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells.In vitro effects of mycophenolic acid on survival, function, and gene expression of pancreatic beta-cells.mTORC1 pathway mediates beta cell compensatory proliferation in 60 % partial-pancreatectomy mice.Donor liver steatosis: A risk factor for early new-onset diabetes after liver transplantation.Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.Implication of mitochondrial cytoprotection in human islet isolation and transplantation.Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factorsPosttransplant diabetes mellitus after pancreas transplantation.Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells.Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors.Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts.AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro, nor after transplantation into immunodeficient mice.Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells.Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control.Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets
P2860
Q30430239-0FA96F7E-DE03-4E6F-867D-70B23BAD6C13Q33738693-AEE9DCDD-C70A-465F-B2F3-CB847C318A39Q34447366-A47786A0-E36E-4B4B-983F-E951512BD211Q36084950-DA383751-534B-4B08-9D86-FBCC40B1A69AQ36349557-CD3E9795-4D67-491B-B376-B66634DDE870Q36538911-7E5881DC-990A-46FF-BA7C-6D491DA6E198Q36590511-C414B7A2-E87C-4AE1-BDCE-A7D24089AAFFQ36981652-FA35C9B9-61CE-4353-9BDA-610D942F641BQ37003015-7EC06F1E-8B05-4004-8FE0-674D71F552CAQ37259485-04AEFA9A-4C93-4F91-AEB3-78CC0E31C016Q37410835-DA361E24-2181-45F8-82EE-9D0DC8DD4743Q37761260-8E1C3B28-4BCA-4994-99A0-88A0D01C641AQ37971089-2FC0D84E-C3E1-4477-8D21-C4B5B99723DBQ38123696-E977D2BD-EB99-403F-82A1-1EF5501B9627Q38341033-715B99D5-657F-4242-A2D3-408300688A37Q39411365-3C2A1453-C8DD-445D-B3B7-303CE0D1B3CFQ40051327-BD1A0E3D-81B2-4163-B63F-D0133FDDD13FQ40627174-57D9BEFE-17E8-4376-9CE6-6256E64B83E5Q41470466-DDD7F458-C661-4155-9898-06F562001DB0Q41770952-64EA0E64-3A40-4240-B988-DFDA4B7F7534Q42209549-54979DF2-80CF-4652-B016-52B65EE3BE41Q44042082-7FB0A2B4-62C0-47DF-842E-1FCF97C95E62Q45018173-A50C0D08-8022-4461-9F46-EDB52377009CQ45103357-04882355-3955-49E4-B069-C2AFE2342CEBQ45883118-12C49F62-3941-4331-B05A-B99E467728B5Q45981052-9069350F-9BAD-4A81-AE1F-2EB8536B4496Q46553066-D401947E-163D-4D63-8DDB-B5CDFC212910Q46914114-D43612F3-A86D-41AA-8279-5D391B356042Q51367878-1DF807C9-BBDB-4CEF-8534-9E2AE30456C8Q51490028-645791FA-504A-47D6-9EB7-4E0C943FC39CQ51990606-044772CD-C3AD-4601-B0F7-7EB006DBAD81Q53612757-0219F78D-7BB1-4095-90CE-5DD0CC485469Q57083088-3E50B32D-4175-4CFB-AE9B-2C4C8E036DF9
P2860
Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Inhibitory effects of immunosu ...... 5 cells and Wistar rat islets.
@en
type
label
Inhibitory effects of immunosu ...... 5 cells and Wistar rat islets.
@en
prefLabel
Inhibitory effects of immunosu ...... 5 cells and Wistar rat islets.
@en
P2093
P1433
P1476
Inhibitory effects of immunosu ...... 5 cells and Wistar rat islets.
@en
P2093
P304
P356
10.1097/00007890-200202150-00007
P577
2002-02-01T00:00:00Z